Hispanic and Latino (HL) cancer survivors are at a critical disadvantage compared with non-
Hispanic White (NHW) patients regarding sociodemographic adversities and access to …

ASCO strives, through research, education, and promotion of the highest quality of patient
care, to create a world where cancer is prevented and every survivor is healthy. In this …

Asian Americans are the only racial/ethnic group in the US for whom cancer is the leading
cause of death in men and women, unlike heart disease for all other groups. Asian …

Centuries of systemic deprivation of the Black population in the United States have yielded
pervasive and long-lasting health consequences 1; although disparities in health and …

A need exists to examine racial disparities in the healthcare arena and the impact on
patients with cancer. Despite ongoing efforts to increase equity in primary healthcare …

ABSTRACT The American Society of Clinical Oncology (ASCO) has embarked on an
intensive campaign to integrate elimination of cancer health disparities into the Society's …

There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

Background: We present and describe tailored strategies to address known barriers to
minority participation in clinical trial research. The strategies used allowed our team to …

Abstract On July 29, 2021, the US Food and Drug Administration's Oncology Center of
Excellence convened Conversations on Cancer. This Conversation, the first ever by the US …

A disproportionate number of cancer deaths occur among racial/ethnic minorities,
particularly African Americans, who have a 33% higher risk of dying of cancer than whites …